|
Interesting. I'm sure there are no conclusive studies about it preventing mets. But then why would MD Anderson pull their trial and give ALL stage I-III patients neoadjuvent herceptin if they didn't believe it would prevent recurrance? Especially if it is that terribly toxic? I mean, they will give it to you without lymph node involvement.....even if your recurrance risk is in the single digits.
|